These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
301 related articles for article (PubMed ID: 24184605)
1. Nucleolar dysfunction in Huntington's disease. Lee J; Hwang YJ; Ryu H; Kowall NW; Ryu H Biochim Biophys Acta; 2014 Jun; 1842(6):785-90. PubMed ID: 24184605 [TBL] [Abstract][Full Text] [Related]
2. Epigenetics of Huntington's Disease. Bassi S; Tripathi T; Monziani A; Di Leva F; Biagioli M Adv Exp Med Biol; 2017; 978():277-299. PubMed ID: 28523552 [TBL] [Abstract][Full Text] [Related]
3. ESET methylates UBF at K232/254 and regulates nucleolar heterochromatin plasticity and rDNA transcription. Hwang YJ; Han D; Kim KY; Min SJ; Kowall NW; Yang L; Lee J; Kim Y; Ryu H Nucleic Acids Res; 2014 Feb; 42(3):1628-43. PubMed ID: 24234436 [TBL] [Abstract][Full Text] [Related]
4. Dysregulation of upstream binding factor-1 acetylation at K352 is linked to impaired ribosomal DNA transcription in Huntington's disease. Lee J; Hwang YJ; Boo JH; Han D; Kwon OK; Todorova K; Kowall NW; Kim Y; Ryu H Cell Death Differ; 2011 Nov; 18(11):1726-35. PubMed ID: 21546905 [TBL] [Abstract][Full Text] [Related]
5. Epigenetic mechanisms of neurodegeneration in Huntington's disease. Lee J; Hwang YJ; Kim KY; Kowall NW; Ryu H Neurotherapeutics; 2013 Oct; 10(4):664-76. PubMed ID: 24006238 [TBL] [Abstract][Full Text] [Related]
6. Non-Cell Autonomous and Epigenetic Mechanisms of Huntington's Disease. Kim C; Yousefian-Jazi A; Choi SH; Chang I; Lee J; Ryu H Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830381 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic regulation in Huntington's disease. Hyeon JW; Kim AH; Yano H Neurochem Int; 2021 Sep; 148():105074. PubMed ID: 34038804 [TBL] [Abstract][Full Text] [Related]
8. Roles of the nucleolus in the CAG RNA-mediated toxicity. Tsoi H; Chan HY Biochim Biophys Acta; 2014 Jun; 1842(6):779-84. PubMed ID: 24269666 [TBL] [Abstract][Full Text] [Related]
9. Expression of expanded CAG transcripts triggers nucleolar stress in Huntington's disease. Tsoi H; Chan HY Cerebellum; 2013 Jun; 12(3):310-2. PubMed ID: 23315009 [TBL] [Abstract][Full Text] [Related]
10. Msh2 acts in medium-spiny striatal neurons as an enhancer of CAG instability and mutant huntingtin phenotypes in Huntington's disease knock-in mice. Kovalenko M; Dragileva E; St Claire J; Gillis T; Guide JR; New J; Dong H; Kucherlapati R; Kucherlapati MH; Ehrlich ME; Lee JM; Wheeler VC PLoS One; 2012; 7(9):e44273. PubMed ID: 22970194 [TBL] [Abstract][Full Text] [Related]
11. Transgenic mice expressing mutated full-length HD cDNA: a paradigm for locomotor changes and selective neuronal loss in Huntington's disease. Reddy PH; Charles V; Williams M; Miller G; Whetsell WO; Tagle DA Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1035-45. PubMed ID: 10434303 [TBL] [Abstract][Full Text] [Related]
12. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD). Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346 [TBL] [Abstract][Full Text] [Related]
13. Full length mutant huntingtin is required for altered Ca2+ signaling and apoptosis of striatal neurons in the YAC mouse model of Huntington's disease. Zhang H; Li Q; Graham RK; Slow E; Hayden MR; Bezprozvanny I Neurobiol Dis; 2008 Jul; 31(1):80-8. PubMed ID: 18502655 [TBL] [Abstract][Full Text] [Related]
14. Epigenetic modifications as novel therapeutic targets for Huntington's disease. Wang F; Fischhaber PL; Guo C; Tang TS Epigenomics; 2014 Jun; 6(3):287-97. PubMed ID: 25111483 [TBL] [Abstract][Full Text] [Related]
15. Specific caspase interactions and amplification are involved in selective neuronal vulnerability in Huntington's disease. Hermel E; Gafni J; Propp SS; Leavitt BR; Wellington CL; Young JE; Hackam AS; Logvinova AV; Peel AL; Chen SF; Hook V; Singaraja R; Krajewski S; Goldsmith PC; Ellerby HM; Hayden MR; Bredesen DE; Ellerby LM Cell Death Differ; 2004 Apr; 11(4):424-38. PubMed ID: 14713958 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of neuronal cell death in Huntington's disease. Sawa A; Tomoda T; Bae BI Cytogenet Genome Res; 2003; 100(1-4):287-95. PubMed ID: 14526190 [TBL] [Abstract][Full Text] [Related]
17. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease. Bithell A; Johnson R; Buckley NJ Biochem Soc Trans; 2009 Dec; 37(Pt 6):1270-5. PubMed ID: 19909260 [TBL] [Abstract][Full Text] [Related]
18. Towards a transgenic model of Huntington's disease in a non-human primate. Yang SH; Cheng PH; Banta H; Piotrowska-Nitsche K; Yang JJ; Cheng EC; Snyder B; Larkin K; Liu J; Orkin J; Fang ZH; Smith Y; Bachevalier J; Zola SM; Li SH; Li XJ; Chan AW Nature; 2008 Jun; 453(7197):921-4. PubMed ID: 18488016 [TBL] [Abstract][Full Text] [Related]